35 episodes
On The Pen: The Weekly Dose Dave Knapp Man On The Mounjaro
-
- Health & Fitness
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
-
On The Pen: The Weekly Dose 6.25.24
Send us a Text Message.Novo Nordisk expansion in the US:https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=168528Generic liraglutidehttps://www.onthepen.com/post/teva-launches-first-ever-generic-glp-1-a-game-changer-for-diabetes-and-weight-managementNew Wegovy Coupon:https://www.wegovy.com/coverage-and-savings/save-on-wegovy.htmlNew Mounjaro Card (tiktok video)https://mounjaro.lilly.com/savings-resourcesTirzepatide (tiktok video):https://www.reuters.com/busi...
-
On The Pen: The Weekly Dose 6.18.24
Send us a Text Message.PBM Reform Form Letter: Link to the Letter: https://www.onthepen.com/post/pbm-reform-form-letter-for-elected-representativesExpress scripts (tiktok video on PBM reform):Link to my video: https://www.youtube.com/watch?v=l0g6RwViOxcMichigan (tiktok video)Link (Madison Muller): https://www.bloomberg.com/news/articles/2024-06-12/michigan-s-largest-insurer-to-drop-weight-loss-drug-coverageAccessibilityLink: https://www.benefitspro.com/2024/06/13/8-ways-to-use-behavioral...
-
Zepbound And Liver Disease
Send us a Text Message.Eli Lilly's phase 2 SYNERGY-NASH study shows tirzepatide effectively resolves MASH and improves fibrosis, offering hope for millions. Read more here: https://www.onthepen.com/post/tirzepatide-shows-promise-in-treating-mash-key-findings-from-the-synergy-nash-studySupport the Show.MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinSOCIAL LINKShttps://www.tikt...
-
On The Pen: The Weekly Dose 6.11.24
Send us a Text Message.Ro.co/supply-trackerFDA shortage update (tiktok video):Link:https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Tirzepatide%20Injection&st=cEASL (European Association for the Study of the Liver) 2024 in Milan ItalyLink: https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-was-superior-placebo-mash-resolution-and-moreLink: https://www.biospace.com/article/mash-clash-between-lilly-and-boehringer-zealand-t...
-
On The Pen: The Weekly Dose 6.4.24
Send us a Text Message.https://ro.co/weight-loss/supply-trackerhttps://www.youtube.com/watch?v=mL_krAas70kNovo Nordisk Advertising:Novo Nordisk launches new advertising campaign "The Power of Wegovy"This advertisement includes the new indication for reduction of cardiovascular riskFor 2023, the #5 advertising spend for a drug was Rybelsus at $191 million. The #6 advertising spend was Ozempic at $187.4 million (increase of 6% from 2022). More than 40% of the 2023 ad spend for Ozempic&nbs...
-
OTP EPS 68: Ro CEO Zach Reitano Talks GLP-1 Supply Tracker
Send us a Text Message.Zachariah Reitano is the founder of Ro, a telehealth company that has a vision of giving consumers more power over their health, he joins #OnThePen to talk all things #mounjaro #zepbound #wegovy #ozempic Reitano is the founder of Ro, a telehealth company that has a vision of giving consumers more power over their health.https://ro.co/weight-loss/supply-tracker/Support the Show.MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaro...